Kaiser Permanente — Honolulu, Hawaii

Kaiser Permanente is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Kaiser Permanente has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Critical Limb Ischemia, Chronic Limb-Threatening Ischemia, Metastatic Renal Cell Carcinoma.

Sponsors: LimFlow, Inc., NewLink Genetics Corporation, Cardiff Oncology.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente?

Kaiser Permanente has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente conducted?

Kaiser Permanente has 6 clinical trials on record, with 1 currently active. Their work covers Critical Limb Ischemia, Chronic Limb-Threatening Ischemia, Metastatic Renal Cell Carcinoma.

Is Kaiser Permanente accredited by Crixeo Health?

Yes — Kaiser Permanente holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Kaiser Permanente?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.